V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20199264 | 20153063 | 1.85 | 87.6 | Palliative (P) | 2017-03-17 | 2019-01-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101404724 |
| 20199272 | 20153064 | 1.67 | 66.5 | Palliative (P) | 2021-06-07 | 2021-06-07 | Docetaxel | N | N | DOCETAXEL | 100800302 |
| 20199282 | 20153065 | 1.53 | 49.9 | Palliative (P) | 2020-02-03 | 2020-02-05 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100483663 |
| 20199289 | 20153066 | 1.6 | 81.05 | Palliative (P) | 2018-03-02 | 2018-03-02 | Docetaxel | 02 | N | DOCETAXEL | 100845783 |
| 20199292 | 20153067 | 1.53 | 62 | Palliative (P) | 2017-09-28 | 2018-05-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100788719 |
| 20199297 | 20153068 | 1.83 | 65 | Palliative (P) | 2019-06-19 | 2019-06-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100285695 |
| 20199301 | 20153069 | 1.63 | 50.1 | null | 2016-04-28 | 2016-04-28 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100830650 |
| 20199303 | 20153070 | 1.66 | 86 | Palliative (P) | 2019-02-26 | 2019-03-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100480061 |
| 20199306 | 20153071 | 1.89 | 50.95 | Palliative (P) | 2017-12-31 | 2018-01-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100449031 |
| 20199314 | 20153072 | 1.55 | null | Adjuvant (A) | 2019-01-22 | 2019-01-23 | Cetuximab + FLUOROURACIL + IRINOTECAN | null | null | DOCETAXEL | 101184659 |
| 20199317 | 20153073 | 1.66 | 86.6 | null | 2016-06-12 | 2017-07-23 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100180656 |
| 20199320 | 20153074 | 1.68 | 63.2 | Adjuvant (A) | 2016-07-27 | 2017-08-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101372486 |
| 20199322 | 20153075 | 1.69 | 89.3 | Palliative (P) | 2019-03-15 | 2019-03-17 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101244097 |
| 20199331 | 20153076 | 1.54 | 102.8 | Palliative (P) | 2018-10-24 | 2018-10-24 | Docetaxel | N | N | DOCETAXEL | 100253921 |
| 20199337 | 20153077 | 1.74 | 68.1 | Neo-adjuvant (N) | 2021-10-01 | 2021-10-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101197098 |
| 20199340 | 20153078 | 1.74 | 69.8 | Palliative (P) | 2018-05-18 | 2018-05-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101545170 |
| 20199351 | 20153079 | 1.91 | 74.4 | Neo-adjuvant (N) | 2017-01-06 | 2017-01-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101156093 |
| 20199368 | 20153080 | 1.78 | 81 | Curative (C) | 2018-05-15 | 2018-05-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101652167 |
| 20199390 | 20153081 | 1.59 | 94.3 | Palliative (P) | 2017-09-15 | 2017-09-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101608511 |
| 20199393 | 20153082 | 1.67 | 88 | null | 2019-10-28 | 2019-10-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100129040 |
| 20199397 | 20153083 | 1.78 | 40.5 | Neo-adjuvant (N) | 2018-07-25 | 2018-08-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101318370 |
| 20199400 | 20153084 | 1.67 | 95.9 | 03 | 2018-10-18 | 2018-11-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100979497 |
| 20199402 | 20153085 | 1.66 | 86.8 | Palliative (P) | 2017-05-04 | 2017-05-08 | Gemcitabine + Capecitabine | 02 | N | DOCETAXEL | 100522122 |
| 20199405 | 20153086 | 1.81 | 66.4 | null | 2021-12-26 | 2022-01-14 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101786330 |
| 20199425 | 20153087 | 1.53 | 60 | Palliative (P) | null | 2019-11-11 | Trastuzumab | N | N | TRASTUZUMAB | 100431800 |
| 20199428 | 20153088 | 1.85 | 54 | Palliative (P) | 2019-04-15 | 2019-09-06 | CETUXIMAB | 02 | N | CETUXIMAB | 100762980 |
| 20199429 | 20153089 | 1.65 | 55.3 | Palliative (P) | 2020-08-27 | 2020-08-27 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101824169 |
| 20199431 | 20153090 | 1.77 | 71 | Curative (C) | null | 2017-07-07 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101728293 |
| 20199449 | 20153091 | 1.65 | 75 | null | 2018-09-20 | 2018-09-21 | CETUXIMAB | 02 | null | CETUXIMAB | 100295491 |
| 20199458 | 20153092 | 1.7 | 88.7 | Palliative (P) | 2016-07-29 | 2016-09-01 | Trastuzumab | 02 | Y | TRASTUZUMAB | 100416429 |
| 20199459 | 20153093 | 1.57 | 73.8 | Curative (C) | null | 2020-08-30 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 101605544 |
| 20199470 | 20153094 | 1.66 | 82 | null | 2019-02-18 | 2019-03-27 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101341656 |
| 20199476 | 20153095 | 1.72 | 92.8 | Palliative (P) | null | 2019-04-18 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 101570887 |
| 20199479 | 20153096 | 1.8 | 89 | null | null | 2016-08-19 | Trastuzumab | null | null | TRASTUZUMAB | 101799479 |
| 20199485 | 20153097 | 1.88 | 92.25 | Curative (C) | 2017-02-12 | 2017-03-05 | CETUXIMAB | 02 | null | CETUXIMAB | 101564567 |
| 20199486 | 20153098 | 1.7 | 81 | null | 2018-02-10 | 2018-08-05 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100054221 |
| 20199502 | 20153099 | 1.85 | 50.1 | Curative (C) | 2020-11-06 | 2020-11-27 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN | 100395277 |
| 20199505 | 20153100 | 1.75 | 84 | null | 2016-12-12 | 2016-12-22 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101339182 |
| 20199506 | 20153101 | 1.64 | 67 | Curative (C) | 2019-05-14 | 2019-05-29 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101226541 |
| 20199507 | 20153102 | 1.65 | 87.1 | Palliative (P) | null | 2017-07-29 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100460933 |
| 20199509 | 20153103 | 1.51 | 72 | Curative (C) | 2017-06-12 | 2017-07-25 | CETUXIMAB | null | N | CETUXIMAB | 100953803 |
| 20199512 | 20153104 | 1.73 | 93.2 | Palliative (P) | 2018-09-26 | 2018-09-26 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100376895 |
| 20199519 | 20153105 | 1.74 | 108.4 | null | 2017-05-21 | 2018-03-04 | Trastuzumab | 02 | null | TRASTUZUMAB | 100680496 |
| 20199537 | 20153106 | 2.08 | 101 | Curative (C) | 2019-12-23 | 2020-01-21 | Trastuzumab | null | N | TRASTUZUMAB | 101565583 |
| 20199540 | 20153107 | 1.75 | 57.5 | Curative (C) | 2020-08-02 | 2020-08-29 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101833480 |
| 20199542 | 20153108 | 1.75 | 71 | Curative (C) | 2020-02-13 | 2020-03-05 | Cetuximab 14 day | null | Y | CETUXIMAB | 101082130 |
| 20199551 | 20153109 | 1.59 | 84.3 | Palliative (P) | 2017-09-03 | 2017-11-12 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100569262 |
| 20199553 | 20153110 | 1.72 | 53 | null | 2019-08-25 | 2019-09-04 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100587928 |
| 20199567 | 20153111 | 1.7 | 62.7 | null | null | 2018-02-06 | Capecitabine + Cisplatin | N | Y | CAPECITABINE + CISPLATIN | 100750223 |
| 20199568 | 20153112 | null | 68.2 | Palliative (P) | null | 2019-05-29 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101703910 |